...
机译:HER家族受体的共表达与非小细胞肺癌(NSCLC)的临床结果相关
Institute of Pathological Anatomy and Histology Perugia University">(1);
S.C. Anatomia Patologica Ospedale Santa Maria della Misericordia">(5);
Institute of Pathological Anatomy and Histology Perugia University">(1);
Institute of Pathological Anatomy and Histology Perugia University">(1);
Medical Oncology Division S. Maria della Misericordia Hospital">(2);
Department of Thoracic Surgery Perugia University">(3);
Department of Electronic and Information Engineering Perugia University">(4);
Institute of Pathological Anatomy and Histology Perugia University">(1);
Institute of Pathological Anatomy and Histology Perugia University">(1);
Medical Oncology Division S. Maria della Misericordia Hospital">(2);
Department of Thoracic Surgery Perugia University">(3);
Medical Oncology Division S. Maria della Misericordia Hospital">(2);
Institute of Pathological Anatomy and Histology Perugia University">(1);
Lung cancer; HER family; Immunohistochemistry; Prognosis; Co-expression;
机译:HER家族受体的共表达与非小细胞肺癌(NSCLC)的临床结果相关
机译:Id1和Id3共表达与经明确放化疗治疗的III-N2期非小细胞肺癌患者的临床结局相关
机译:54LBA胰岛素样生长因子受体1(IGF-1R)和表皮生长因子受体(EGFR)的高共表达与切除的非小细胞肺癌(NSCLC)患者预后差有关
机译:使用有效的体内技术(Gilupi Cellcollector
机译:早期非小细胞肺癌临床结果的预处理辐射瘤模型(NSCLC)
机译:Id1和Id3共表达与经明确放化疗治疗的III-N2期非小细胞肺癌患者的临床结局相关
机译:Id1和Id3共表达与经明确放化疗治疗的III-N2期非小细胞肺癌患者的临床结局相关